Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GMAB compared with NUVL: revenue, margins and what each company keeps, and the suppliers and customers both name
GMAB
Genmab A/S
Change
Mkt cap
Revenue
Revenue
NUVL
Nuvalent, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
GMAB
Genmab A/S
vs
NUVL
Nuvalent, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only GMAB
1
COAG
Hemab Therapeutics
customer
Shared
0
No disclosed counterparties: NUVL.
Only NUVL
0
None
Role chip = supplier or customer
Source: SEC EDGAR
GMAB
Genmab A/S
Change
55.70
▼
−2.38%
Mkt cap
$36.7B
NUVL
Nuvalent, Inc.
Change
123.96
▲
+0.02%
Regular session
Sep 2 '83
Mkt cap
$9.8B
vs
Compare
Regular session
Sep 2 '83
GMAB
Genmab A/S
vs
NUVL
Nuvalent, Inc.
55.70
▼
−2.38%
Price
123.96
▲
+0.02%
$36.7B
Mkt cap
$9.8B
Change
Change
GMAB
55.70
▼
−2.38%
vs
NUVL
123.96
▲
+0.02%
Regular session
Sep 2 '83